Evidence map›Paper›PMID 40856035›Full record

ArticleActa anaesthesiologica Scandinavica2025

Long-Term Outcomes After Cardiac Arrest: Protocol for the Extended Follow-Up Sub-Study of the STEPCARE Trial.

Gisela Lilja, Dorit Töniste, Frances Bass, Janus Christian Jakobsen, Niklas Nielsen, Markus B Skrifvars, Susann Ullén, Josef Dankiewicz, Helena Levin, Johanna Hästbacka and 34 more

Abstract readClinical Trial Protocol
In one paragraph

Article in Acta anaesthesiologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors.

Gisela LiljaDepartment of Clinical Sciences, Lund University, Lund, Sweden.ORCID 0000-0003-1860-1456
Dorit TönisteDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Frances BassCritical Care Program, The George Institute for Global Health, University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.
Janus Christian JakobsenCopenhagen Trial Unit, Centre for Clinical Intervention Research Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Niklas NielsenDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Markus B SkrifvarsDepartment of Anesthesia and Intensive Care Medicine, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Susann UllénClinical Studies Sweden Forum South, Skåne University Hospital, Lund, Sweden.
Josef DankiewiczDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Helena LevinDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Johanna HästbackaDepartment of Anesthesia and Intensive Care, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
Marion Moseby KnappeDepartment of Clinical Sciences, Lund University, Lund, Sweden.ORCID 0000-0001-8160-5957
Manoj SaxenaCritical Care Program, The George Institute for Global Health, University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.
Matt P WiseAdult Critical Care, University Hospital of Wales, Cardiff, UK.
Paul YoungIntensive Care Unit, Wellington Hospital, Wellington, New Zealand.
Anders AnemanIntensive Care Unit, Liverpool Hospital, South Western Sydney Local Health District, Sydney, New South Wales, Australia.ORCID 0000-0003-2096-5304
Koen AmelootDepartment of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Jade M ColeAdult Critical Care, University Hospital of Wales, Cardiff, UK.
Tobias CronbergDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Anthony DelaneyCritical Care Program, The George Institute for Global Health, University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.
Patrick DruwéDepartment of Clinical Sciences, Lund University, Malmö, Sweden.
Joachim DuringDepartment of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.
Tobias GrafUniversity Heart Center Lübeck, Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), Lübeck, Germany.ORCID 0000-0003-4038-147X
Matthias HaenggiInstitute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.
Katarina HeimburgDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Manuela ItensDepartment of Intensive Care Medicine, Inselspital, University Hospital Bern, Bern, Switzerland.
Caroline Kamp BarkholtCopenhagen Trial Unit, Centre for Clinical Intervention Research Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.ORCID 0000-0002-7756-4694
Thomas R KeebleEssex Cardiothoracic Centre, Essex, UK.ORCID 0000-0001-8695-7994
Christoph LeithnerDepartment of Neurology and Experimental Neurology, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität Zu Berlin, Berlin, Germany.
Anna LybeckDepartment of Clinical Sciences, Lund University, Lund, Sweden.ORCID 0000-0001-7574-3958
Andreas LundinDepartment of Anesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Peter McGuiganRegional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK.ORCID 0000-0001-5766-990X
Annerose MengelDepartment of Neurology and Stroke, University Tuebingen, Tuebingen, Germany.
Tuomas OksanenDepartment of Anesthesia and Intensive Care Medicine, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
John RidgwayOccupational Therapy Department, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Luis RomundstadDepartment of Anesthesia and Intensive Care Medicine, Division of Emergencies and Critical Care Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-0552-1668
Claudia SchragClinic for Intensive Care Medicine, HOCH Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Pascal StammetDepartment of Anesthesia and Intensive Care, Centre Hospitalier De Luxembourg, Luxembourg, Luxembourg.ORCID 0000-0002-0298-1012
Anna TippettCritical Care Program, The George Institute for Global Health, University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.
Matthew ThomasDepartment of Intensive Care Medicine, University Hospitals, Bristol and Weston, Bristol, UK.
Joonas TirkkonenDepartment of Anesthesia and Intensive Care, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
Johan UndénDepartment of Clinical Sciences, Lund University, Malmö, Sweden.
Bala VenkateshCritical Care Program, The George Institute for Global Health, University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.
Marjaana TiainenDepartment of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Naomi HammondCritical Care Program, The George Institute for Global Health, University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.

Funding

ALF-project funding within the Swedish Health CareHealth Research Council of New ZealandHospital district of Helsinki and Uusimaa 199449National Health and Medical Research Council APP2015994scientific council from Region HallandSkåne County Council's Research and Development FoundationSkane University Hospital FoundationsThe Academy of Finland 341277the Hans-Gabriel and Alice Trolle-Wachtmeisters Foundation for Medical ResearchThe Swedish Research Council
6 · The paper itself

Abstract

backgroundThe international multi-center randomized controlled STEPCARE-trial will investigate optimal management of sedation, temperature, and mean arterial pressure (MAP) during intensive care in out-of-hospital cardiac arrest (OHCA) patients due to various etiologies. The primary outcome is mortality at 6 months. This protocol describes an extended follow-up sub-study of the STEPCARE-trial with the main objective to provide detailed long-term outcomes for survivors and caregivers. It will focus on potential neuroprotection and improved recovery for different targets of sedation, temperature, and MAP management at 6 and 12 months post-OHCA.

methodsAll survivors and one caregiver per survivor at selected STEPCARE sites will be invited to participate. Randomization is stratified by site. This sub-study extends the main STEPCARE follow-up at 6 months by undertaking detailed assessments, face-to-face meetings, inclusion of a caregiver, and repeating the assessments at 12 months. Our main outcome for survivors is cognitive function measured by the Montreal Cognitive Assessment, and for caregivers, the caregiver burden measured by the Zarit Burden Interview. Additional outcomes include symptoms of anxiety, depression, post-traumatic stress disorder, fatigue, physical function, life satisfaction, and life impact (disability), assessed by psychometrically robust measures. The estimated sample size is 600. Efforts to improve interrater reliability and decrease missing data are integral to the study design.

conclusionThese detailed long-term outcomes will explore the possible benefits or risks of fever, sedation, and blood pressure management in post-OHCA survivors. Additionally, this study will explore survivorship after cardiac arrest from various perspectives, including different causes of arrest. CLINICALTRIALS: gov: NCT0207942.

Indexed as

Out-of-Hospital Cardiac ArrestCaregiversFollow-Up StudiesHumansMulticenter Studies as TopicRandomized Controlled Trials as TopicSurvivorsTreatment Outcomecaregiverscognitionfollow‐up studiesoutcomesout‐of‐hospital cardiac arrestrandomized controlled trial

Identifiers

PMID40856035
PMCPMC12379104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.